Statistics

Total Visits

Views
Randomized, phase II trial comparing continuous versus intermittent capecitabine (X) monotherapy for metastatic breast cancer (MBC): Results from the GEICAM 2009-05 study59

Select a period of time:

Number of views in the range

Views
Randomized, phase II trial comparing continuous versus intermittent capecitabine (X) monotherapy for metastatic breast cancer (MBC): Results from the GEICAM 2009-05 study8

Views

Views
December 20251
January 20260
February 20260
March 20260
April 20260
May 20267
June 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States4
Argentina1
Switzerland1
Germany1
Mexico1
 

Top cities views

Views
Hunucmá1
Los Angeles1
Salta1